FMS analyst estimates
Fresenius Medical Care (FMS) analyst ratings, the average price target and its range, and every firm's latest call.
FMS analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 29, 2026 | Berenberg Bank | Berenberg Downgrades Fresenius Medical Care (FMS) to Hold | $24.00 |
| Aug 6, 2026 | Bernstein | Fresenius Medical price target raised to $25.80 from $25.50 at Bernstein | $25.80 |
| Aug 5, 2026 | Truist Financial | Fresenius Medical price target lowered to $25 from $26 at Truist | $25.00 |
| Jul 28, 2026 | BNP Paribas | Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas | $19.90 |
| Jan 5, 2026 | Truist Financial | Fresenius Medical price target raised to $28 from $26 at Truist | $28.00 |
| May 15, 2024 | Truist Financial | Fresenius Medical price target raised to $24 from $21 at Truist | $24.00 |
| Jan 2, 2023 | Jefferies | Fresenius Medical downgraded to Underperform from Buy at Jefferies | $11.70 |
| Jun 22, 2022 | Truist Financial | Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $27 | $27.00 |
- 11 firms rate FMS: 7 buy, 2 hold, 2 sell.
- The average price target is $23.68 from 4 analysts, from $19.90 to $25.80.
Updated 2026-11-02 23:10 UTC